Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Colorectal Neoplasms × Abituzumab × Clear all

Phase

Status

Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Oxaliplatin 20 Fluorouracil 20 Leucovorin 19 Bevacizumab 16 Cetuximab 13 Irinotecan 12 Capecitabine 8 regorafenib 5 Radiotherapy 5 Nivolumab 5 aflibercept 4 Radiosurgery 4 Neoadjuvant Therapy 4 Magnetic Resonance Spectroscopy 4 Drug Therapy 4 Biopsy 4 pembrolizumab 3 durvalumab 3 atezolizumab 3 Specimen Handling 3 Folfox protocol 3 Cyclophosphamide 3 Chemotherapy, Adjuvant 3 trifluridine tipiracil drug combination 2 tremelimumab 2 tislelizumab 2 poly(I).poly(c12,U) 2 futuximab 2 fludarabine 2 avelumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03688230 2020-03-18

AMELION

SFJ Pharmaceuticals, Inc.

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡